This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Metoclopramide confers an increased risk for the initiation of treatment generally reserved for the management of idiopathic Parkinson's disease.
In summary, we found that metoclopramide use confers an increased risk for the initiation of a treatment generally reserved for the management of idiopathic Parkinson's Disease. Such polypharmacy may represent the misdiagnosis of Parkinson's Disease in older patients suffering drug-induced parkinsonian symptoms.
Previous Slide Contents Next Slide